Otsuka Holdings' R&D ratio to revenue FY 2013-2022
The research and development (R&D) ratio to the revenue of Otsuka Holdings Co., Ltd. in the fiscal year 2022 was around 16 percent, a slight increase from the previous year. Otsuka Holdings is a holding company of multiple group companies worldwide such as Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Otsuka Chemical.